Catherine S. Hibbert

Array ( [id] => 20335304 [patent_doc_number] => 20250339424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA [patent_app_type] => utility [patent_app_number] => 19/270674 [patent_app_country] => US [patent_app_date] => 2025-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19270674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20362838 [patent_doc_number] => 20250352650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-20 [patent_title] => TOPICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 19/252084 [patent_app_country] => US [patent_app_date] => 2025-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19252084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20165051 [patent_doc_number] => 20250257097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES [patent_app_type] => utility [patent_app_number] => 19/177248 [patent_app_country] => US [patent_app_date] => 2025-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19177248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20098863 [patent_doc_number] => 20250228799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => SALT OF A PHARMACEUTICAL COMPOUND [patent_app_type] => utility [patent_app_number] => 19/172147 [patent_app_country] => US [patent_app_date] => 2025-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19172147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20293812 [patent_doc_number] => 20250319055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => COMPOSITIONS FOR TREATING GENITAL HERPES AND METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 19/026003 [patent_app_country] => US [patent_app_date] => 2025-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19026003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19656910 [patent_doc_number] => 20240423975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA [patent_app_type] => utility [patent_app_number] => 18/824121 [patent_app_country] => US [patent_app_date] => 2024-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33081 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19707731 [patent_doc_number] => 20250017873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => TOPICAL PEEL-OFF CREAM FOR NUMBING PAIN DURING SKIN-RELATED PROCEDURES [patent_app_type] => utility [patent_app_number] => 18/773435 [patent_app_country] => US [patent_app_date] => 2024-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18773435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19896835 [patent_doc_number] => 12274729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-15 [patent_title] => Formulations and methods for skin care or hyaluronic acid synthesis [patent_app_type] => utility [patent_app_number] => 18/764024 [patent_app_country] => US [patent_app_date] => 2024-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 61 [patent_no_of_words] => 43182 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19526532 [patent_doc_number] => 20240350434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => METHODS FOR TREATING MAJOR DEPRESSIVE DISORDER AND TREATMENT-RESISTANT DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/760811 [patent_app_country] => US [patent_app_date] => 2024-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18760811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20057285 [patent_doc_number] => 20250195507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => Use of Pirfenidone (PFD) Combined With Nintedanib (BIBF 1120) in Preparation of Drug for Treating Pneumoconiosis [patent_app_type] => utility [patent_app_number] => 18/680893 [patent_app_country] => US [patent_app_date] => 2024-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18680893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462347 [patent_doc_number] => 20240316016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => EFFECTIVE TREATMENT OF DEPRESSION IN PATIENTS HAVING IMPAIRED LEARNING AND/OR MEMORY OR CERTAIN EEG CHARACTERISTICS WITH A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT [patent_app_type] => utility [patent_app_number] => 18/670632 [patent_app_country] => US [patent_app_date] => 2024-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19624035 [patent_doc_number] => 12162839 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-12-10 [patent_title] => 4,5-bis(4-bromophenyl)-2-(4-bromophenyl)-1-hexyl-1H-imidazole as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/668552 [patent_app_country] => US [patent_app_date] => 2024-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4278 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18668552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691205 [patent_doc_number] => 20250009750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => METHODS OF TREATING DISORDERS ASSOCIATED WITH EYA OVEREXPRESSION AND MUTATIONS [patent_app_type] => utility [patent_app_number] => 18/666636 [patent_app_country] => US [patent_app_date] => 2024-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19550908 [patent_doc_number] => 12134604 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-11-05 [patent_title] => 1-[4,5-bis(4-chlorophenyl)-1-hexyl-1H-imidazol-2-yl]-2-naphthol as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/662706 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4145 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19701421 [patent_doc_number] => 12195430 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-14 [patent_title] => 6-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)hexanoic acid as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/631518 [patent_app_country] => US [patent_app_date] => 2024-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4311 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19722728 [patent_doc_number] => 20250025479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => TRANSPORE DELIVERY OF STEROIDS AND LARGE MOLECULES [patent_app_type] => utility [patent_app_number] => 18/581836 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20811 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19692815 [patent_doc_number] => 20250011360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => PREPARATION AND USES OF OBETICHOLIC ACID [patent_app_type] => utility [patent_app_number] => 18/436527 [patent_app_country] => US [patent_app_date] => 2024-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19279894 [patent_doc_number] => 20240216366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING A DIPHENYLPYRAZINE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 18/435817 [patent_app_country] => US [patent_app_date] => 2024-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19186192 [patent_doc_number] => 20240165105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => TOPICAL NALOXONE COMPOSITIONS AND METHODS FOR USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/429339 [patent_app_country] => US [patent_app_date] => 2024-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17521 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18429339 [rel_patent_id] =>[rel_patent_doc_number] =>)